Qingfeng Pharma Group

English

中文

Home

Providing sustainable and high-quality service for human health

Become a leading provider of medical health products and service

Innovating, Efficiency, Striving, Sharing

04/01

2022

Qingfeng Pharmaceutical Group Lenvatinib Mesylate capsule was approved for listing

A few days ago, the official website of the NMPA released the drug approval certificate. The information showed on March 22, the Lenvatinib capsule developed by Hangzhou Qingyue and Shanxiang pharm...

08/03

2021

Qingfeng was listed as the "best industrial enterprise in China's pharmaceutical R & D product line"

On August 1, 2021 (the 38th) national pharmaceutical industry information annual conference was grandly opened in Jinan, Shandong Province. The conference officially released the list of the best ...

07/06

2021

Qingfeng Pharma. new method for synthesizing lacosamide won the Chinese patent Excellence Award

On June 24, China National Intellectual Property Administration officially announced the list of winners of the 22nd China Patent Award. Qingfeng Pharma. new method for synthesizing lacosamide won ...